Discover key insights from Clearmind Medicine Inc.'s January 2025 Form 6-K, detailing shareholder meeting results, regulatory compliance, and executive updates.
Clearmind Medicine Inc. announces a Form 6-K filing detailing a European Patent Application for a binge behavior psychedelic treatment. Key insights on IP and regulatory compliance.
Discover key insights from Clearmind Medicine Inc.'s January 2025 SEC Form 6-K, including a new patent for binge behavior treatment, enhancing its market position and compliance.
Discover Clearmind Medicine Inc.'s latest Form 6-K filing detailing IRB approval for its FDA-regulated clinical trial, ensuring compliance with SEC regulations.